Open AccessSpotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
Author(s) -
Theodora Anagnostou,
Mark Litzow
Publication year - 2018
Publication title -
blood and lymphatic cancer targets and therapy
Language(s) - English
Resource type - Journals
ISSN - 1179-9889
DOI - 10.2147/blctt.s169529
Subject(s) - ponatinib , myeloid leukemia , lymphoblastic leukemia , medicine , philadelphia chromosome , selection (genetic algorithm) , oncology , leukemia , cancer research , genetics , biology , dasatinib , gene , chromosomal translocation , computer science , imatinib , artificial intelligence
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom